Contact
Please use this form to send email to PR contact of this press release:
Alder BioPharmaceuticals, Inc. Announces Offering of $200 Million of Convertible Senior Notes Due 2025
TO:
Please use this form to send email to PR contact of this press release:
Alder BioPharmaceuticals, Inc. Announces Offering of $200 Million of Convertible Senior Notes Due 2025
TO: